ArticleiScience2023
A combination therapy of bortezomib, CXCR4 inhibitor, and checkpoint inhibitor is effective in cholangiocarcinoma
Ling Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleiScience2023
Ling Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.